Publication | Closed Access

Novel approach of multi-targeted thiazoles and thiazolidenes toward anti-inflammatory and anticancer therapy—dual inhibition of COX-2 and 5-LOX enzymes

Medicinal ChemistryDrug TargetingMedicineNovel ApproachPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyDrug DiscoveryMulti-targeted Thiazoles5-Lox Enzymes